NICE Approves Transformative Multiple Myeloma T...

By Rene Pretorius

June 16, 2025

Summary NICE has approved a novel combination therapy for multiple
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
What are the Plans and Implications for Keytruda´s Biosimilar
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
Pluvicto Prostate Cancer Trial: Phase III Results
HPV-Related Cancer Trends in South Africa 2011-2021
First At-Home HPV Testing Approval: FDA Clears Teal Wand
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
Trodelvy Keytruda Combination Delivers Breakthrough Results in Metastatic Tri...
AI Pediatric Sarcoma Diagnosis: Improving Speed and Accuracy in Cancer Classi...
FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough i...
Advancing Pediatric Leukemia Trial: Precision Medicine and Transformative Res...